The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) increases mortality rates in older adults and those with comorbidities. Individuals with certain comorbidities may have a poor immune response and require early booster vaccines. We aimed to assess the immune response after two doses of Ch...

全面介绍

书目详细资料

Principais autores:	Thachanun Porntharukchareon, Wipada Chartisathian, Manassamon Navinpipat, Chayanee Samdaengpan, Kunsuda Cheirsilpa, Aimwipa Lueprasitsakul, Supanat Worawichawong, Viroj Muangsillapasart, Pratya Pumuthaivirat, Bothamai Dechates, Supamas Sirisreetreerux, Taweegrit Siripongboonsitti, Vimonsri Rangsrisaeneepitak, Kerati Jirawattanapalin, Kriangkrai Tawinprai
格式:	Artigo
语言:	Inglês
出版:	Taylor & Francis Group 2023-08-01
丛编:	Human Vaccines & Immunotherapeutics
主题:	chadox1 ncov-19 vaccine comorbidity immunogenicity covid-19
在线阅读:	http://dx.doi.org/10.1080/21645515.2023.2251850
标签:	添加标签 没有标签, 成为第一个标记此记录!